|
|
Research Management and Support
|
RMS2008
|
$336,082,664
|
$708,000
|
N/A
|
National Cancer Institute
|
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$31,655
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
|
Clinical study of AdV-tk radiogene therapy for malignant glioma
|
5R44CA107745-04
|
$794,415
|
$794,415
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
|
1P20CA138018-01
|
$135,639
|
$33,910
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Brain cancer in Eastern Nebraska case-control study
|
Z01 CP010119-02210
|
$12,528
|
$12,528
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
CANCER INFORMATION SERVICE
|
N02CO511003-005
|
$630,200
|
$11,974
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Stem Cells as Delivery Vehicles and Imaging Probes for Glioma Gene Therapy
|
1R21CA129801-01A1
|
$163,125
|
$163,125
|
ALI, SYED
|
HENRY FORD HEALTH SYSTEM
|
|
|
Cellular MRI in Glioma and Radiation Necrosis
|
5R01CA122031-02
|
$247,950
|
$247,950
|
ALI, SYED
|
HENRY FORD HEALTH SYSTEM
|
|
|
Protein Kinase C and GSTP1 interactions in glioma drug resistance
|
1R01CA127872-01A2
|
$316,728
|
$316,728
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
|
Novel Targeted Therapeutics for Cental Nervous System Malignancies
|
5R01CA112519-03
|
$327,069
|
$163,535
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-03
|
$335,708
|
$335,708
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Therapeutic approaches that target cancer cell metabolism
|
1K23CA120862-01A2
|
$137,295
|
$41,189
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Autophagy inhibition as a therapeutic strategy for glioblastoma mutliforme
|
1R21CA133898-01
|
$369,053
|
$369,053
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Children's Oncology Group Statistics and Data Center Grant
|
2U10CA098413-06
|
$5,717,149
|
$171,514
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
|
Mechanisms in Perinatal Carcinogenesis
|
Z01 BC 005352
|
$546,189
|
$54,619
|
Anderson, Lucy
|
CCR (NCI)
|
|
|
Elimination of Carcinogen-Induced Tumor Stem Cells by ATF5 Loss of Function.
|
1R21CA126924-01A2
|
$171,000
|
$171,000
|
Angelastro, James
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
Targeting ATF5 for intervention in brain cancer
|
5F31CA123711-02
|
$30,513
|
$30,513
|
ARIAS, ANGELO
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
Patient-specific therapy of glioblastoma using lightly-labeled [14C]-temozolomide
|
1R43CA134184-01
|
$102,900
|
$102,900
|
Arjomand, Ali
|
ACCIUM BIOSCIENCES, INC.
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$19,065
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Protein Folding Mechanism
|
Z01 BC 010276
|
$519,254
|
$103,851
|
Bai, Yawen
|
CCR (NCI)
|
|
|
Pten and P13K regulation of growth and neoplasia in the brain
|
9R01CA135554-06A1
|
$399,518
|
$399,518
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Suppressor of fused gene in Carcinogenesis
|
5R01CA093908-05
|
$254,246
|
$83,901
|
BALE, ALLEN
|
YALE UNIVERSITY
|
|
|
Clinical Pharmacology of Anticancer Drugs
|
Z01 BC 011080
|
$936,285
|
$93,629
|
Balis, Frank
|
CCR (NCI)
|
|
|
NMR Monitoring of Temperature and Its Biological Effects
|
5R33CA110107-03
|
$269,839
|
$40,476
|
BANSAL, NAVIN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
5U01CA105706-05
|
$70,948
|
$69,529
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Imaging of gene expression in glioblastoma
|
5R01CA109620-03
|
$277,775
|
$277,775
|
Basilion, James
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
UCLA Cancer Education and Career Development Program
|
5R25CA087949-09
|
$507,895
|
$101,579
|
Bastani, Roshan
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-08
|
$518,992
|
$518,992
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors
|
5K24CA125440-02
|
$187,934
|
$187,934
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
AZD2171 and chemoradiation for newly diagnosed glioblastoma
|
5R01CA129371-02
|
$583,728
|
$583,728
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
NABTT-New Approaches to Brain Tumor Therapy (CNSC)
|
5U01CA062406-14
|
$57,838
|
$56,681
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$18,805
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$8,717
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$3,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$10,037
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$814,924
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Imaging and Tissue Biomarkers in the Treatment of Brain Tumors
|
5P01CA118816-02
|
$2,188,358
|
$2,188,358
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-07
|
$2,327,870
|
$2,327,870
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Perivascular Invasion of GBMs
|
5R01CA113382-03
|
$266,285
|
$266,285
|
BERGERS, GABRIELE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Geisinger Clinical Oncology Program
|
2U10CA035448-25
|
$599,474
|
$5,995
|
BERNATH, ALBERT
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-10
|
$537,840
|
$80,676
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-30
|
$237,038
|
$23,704
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Statistical Methods for Analysis of Failure Time Data
|
5R01CA075971-10
|
$238,926
|
$179,195
|
Betensky, Rebecca
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
|
Molecular Profiling and Candidate Gene Analysis in Pediatric Gliomas
|
1R21CA133173-01
|
$222,188
|
$222,188
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Genetics of pediatric rhabdoid tumors
|
2R01CA046274-17A2
|
$266,860
|
$88,064
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Brain Tumors - Immunological and Biological Studies
|
4R37CA011898-38
|
$670,357
|
$670,357
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
|
SPORE in Brain Cancer
|
5P50CA108786-05
|
$74,190
|
$74,190
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
|
Improving Suicide Genes for Cancer Gene Therapy
|
5R01CA085939-09
|
$263,260
|
$89,508
|
BLACK, MARGARET
|
WASHINGTON STATE UNIVERSITY
|
|
Total relevant funding to Brain for this search: $137,013,491
|
